Publicacións nas que colabora con RAMON MARTINEZ PACHECO (79)

2017

  1. SEM-image textural features and drug release behavior of Eudragit-based matrix pellets

    Journal of Drug Delivery Science and Technology, Vol. 42, pp. 292-298

  2. Tratado de tecnología farmacéutica

    Síntesis

2016

  1. Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets

    International Journal of Pharmaceutics, Vol. 514, Núm. 1, pp. 290-295

2015

  1. 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics

    Molecular Pharmaceutics, Vol. 12, Núm. 11, pp. 4077-4084

  2. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization

    Drug Development and Industrial Pharmacy, Vol. 41, Núm. 3, pp. 362-368

2013

  1. Chitosan-kaolin coprecipitate as disintegrant in microcrystalline cellulose-based pellets elaborated by extrusion-spheronization

    Pharmaceutical Development and Technology, Vol. 18, Núm. 1, pp. 137-145

  2. Effect of storage conditions on the stability of β-lapachone in solid state and in solution

    Journal of Pharmacy and Pharmacology, Vol. 65, Núm. 6, pp. 798-806

2012

  1. Fast dissolving β-lapachone particles and tablets: An approach using surface adsorption technique

    Drug Development and Industrial Pharmacy, Vol. 38, Núm. 7, pp. 866-871

  2. Temperature-sensitive gels for intratumoral delivery of β-lapachone: Effect of cyclodextrins and ethanol

    The Scientific World Journal, Vol. 2012

2011

  1. A comparison of chitosan-silica and sodium starch glycolate as disintegrants for spheronized extruded microcrystalline cellulose pellets

    Drug Development and Industrial Pharmacy, Vol. 37, Núm. 7, pp. 825-831

  2. Co-processed MCC-Eudragit® e excipients for extrusion-spheronization

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 79, Núm. 3, pp. 658-663

  3. Light effect on the stability of β-lapachone in solution: Pathways and kinetics of degradation

    Journal of Pharmacy and Pharmacology, Vol. 63, Núm. 9, pp. 1156-1160

2010

  1. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization

    Pharmaceutical Development and Technology, Vol. 15, Núm. 6, pp. 626-635

  2. Modelling of porosity and waterfronts in cellulosic pellets for understanding drug release behavior

    International Journal of Pharmaceutics, Vol. 388, Núm. 1-2, pp. 101-106

2009

  1. Fractal analysis of SEM images and mercury intrusion porosimetry data for the microstructural characterization of microcrystalline cellulose-based pellets

    Acta Materialia, Vol. 57, Núm. 1, pp. 295-303

  2. Validação da metodologia analítica e desenvolvimento do teste de dissolução para o antineoplásico beta-lapachona

    Latin American Journal of Pharmacy, Vol. 28, Núm. 6, pp. 805-811

2008

  1. Dissolution rate enhancement of the novel antitumoral β-lapachone by solvent change precipitation of microparticles

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 69, Núm. 3, pp. 871-877

  2. In situ photopolymerization-coated pellets for pH-dependent drug delivery

    European Polymer Journal, Vol. 44, Núm. 8, pp. 2629-2638

  3. Incidence of drying on microstructure and drug release profiles from tablets of MCC-lactose-Carbopol® and MCC-dicalcium phosphate-Carbopol® pellets

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 69, Núm. 2, pp. 675-685

  4. Konjac glucomannan and konjac glucomannan/xanthan gum mixtures as excipients for controlled drug delivery systems. Diffusion of small drugs

    International Journal of Pharmaceutics, Vol. 349, Núm. 1-2, pp. 11-18